» Articles » PMID: 30577589

Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing

Overview
Publisher MDPI
Date 2018 Dec 23
PMID 30577589
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

is an emerging pathogen that needs to be controlled effectively due to its association with a high mortality rate. The presence of biofilms on dry surfaces has been shown to be widespread in healthcare settings. We produced a dry surface biofilm (DSB) on stainless steel surfaces following sequential hydration and desiccation cycles for 12 days. The ASTM2967-15 was used to measure the reduction in viability of 12 commercially wipe-based disinfectants and sodium hypochlorite (1000 ppm) against DSB. We also evaluated transferability and biofilm regrowth post-treatment. A peracetic acid (3500 ppm) product and two chlorine-based products (1000 ppm available chlorine) were successful in reducing viability and delaying DSB regrowth. However, 50% of the products tested failed to decrease viability, 58% failed to prevent its transferability, and 75% did not delay biofilm regrowth. Using three different parameters to measure product efficacy provided a practical evaluation of product effectiveness against DSB. Although log reduction in viability is traditionally measured, transferability is an important factor to consider from an infection control and prevention point of view as it allows for determination of whether the surface is safe to touch by patients and hospital staff post-treatment.

Citing Articles

Current Perspectives of Antifungal Therapy: A Special Focus on .

Ganeshkumar A, Muthuselvam M, Lima P, Rajaram R, Junqueira J J Fungi (Basel). 2024; 10(6).

PMID: 38921394 PMC: 11205254. DOI: 10.3390/jof10060408.


Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece.

Poulopoulou A, Sidiropoulou A, Sarmourli T, Zachrou E, Michailidou C, Zarras C Med Mycol. 2024; 62(7).

PMID: 38877671 PMC: 11232515. DOI: 10.1093/mmy/myae062.


The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.

Jones C, Neill C, Borman A, Budd E, Cummins M, Fry C J Med Microbiol. 2024; 73(5).

PMID: 38771623 PMC: 11165919. DOI: 10.1099/jmm.0.001820.


Pathogenesis, Prophylaxis, and Treatment of .

Preda M, Chivu R, Ditu L, Popescu O, Manolescu L Biomedicines. 2024; 12(3).

PMID: 38540174 PMC: 10968176. DOI: 10.3390/biomedicines12030561.


Efficiency and novelty of using environmental swabs for dry-surface biofilm recovery.

Watson F, Wilks S, Chewins J, Keevil B Access Microbiol. 2024; 6(2).

PMID: 38482344 PMC: 10928391. DOI: 10.1099/acmi.0.000664.v4.


References
1.
Estrela C, Estrela C, Barbin E, Spano J, Marchesan M, Pecora J . Mechanism of action of sodium hypochlorite. Braz Dent J. 2002; 13(2):113-7. DOI: 10.1590/s0103-64402002000200007. View

2.
Biswal M, Rudramurthy S, Jain N, Shamanth A, Sharma D, Jain K . Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect. 2017; 97(4):363-370. DOI: 10.1016/j.jhin.2017.09.009. View

3.
Arauz A, Caceres D, Santiago E, Armstrong P, Arosemena S, Ramos C . Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses. 2017; 61(1):44-47. DOI: 10.1111/myc.12709. View

4.
Morales-Lopez S, Parra-Giraldo C, Ceballos-Garzon A, Martinez H, Rodriguez G, Alvarez-Moreno C . Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia. Emerg Infect Dis. 2016; 23(1):162-164. PMC: 5176232. DOI: 10.3201/eid2301.161497. View

5.
Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H . Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009; 53(1):41-4. DOI: 10.1111/j.1348-0421.2008.00083.x. View